Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients

Table 2

Measurement of autoantibody abundancies in the study sample of the German population-based Gutenberg Health Study (2007–2012).

Autoantibody	Missing values (%)	No RVO	RVO	value
ACO2	6.3	2074 [728, 4173]	3160 [1677, 5522]	0.010
ACTA1	18.1	3036 [1473, 6445]	3178 [1903, 5223]	0.678
ALB	0.3	11092 [5271, 26362]	17087 [9570, 30900]	0.032
APOA1	23.7	16366 [8269, 31017]	17724 [12739, 33491]	0.158
CRYB	0.7	10868 [5054, 20103]	11281 [7384, 18234]	0.519
BDNF	1.0	8822 [3083, 20522]	12841 [5202, 19563]	0.231
CA2	23.0	38521 [18099, 66345]	51944 [29945, 91025]	0.011
CALR	10.1	2685 [1065, 8259]	4043 [1603, 11782]	0.024
CKB	24.0	132 [51, 385]	165 [70, 335]	0.844
CLUS	0.7	3754 [1896, 7731]	3829 [2254, 6237]	0.832
DCD	27.5	1132 [451, 2406]	2063 [1190, 3707]	<0.001
DPYSL2	1.7	1519 [661, 4406]	2759 [1460, 6229]	0.003
EIF4A1	13.2	3019 [1174, 7473]	4587 [1741, 8618]	0.086
ENO2	0.7	7902 [3529, 15917]	7836 [4756, 15253]	0.590
GAPDH	0.7	3744 [1915, 7447]	4692 [3010, 7110]	0.033
GFAP	0.3	3285.50 [1555.65, 7164.40]	5693.41 [2579.22, 8549.41]	0.009
GLUL	5.6	703.88 [285.72, 1616.39]	1547.99 [598.85, 2849.82]	0.002
GNB1	30.0	54.50 [17.62, 125.47]	26.88 [8.84, 90.49]	0.134
GPD2	18.1	3081.16 [1549.40, 7339.39]	3743.75 [2143.56, 7727.56]	0.216
groEL2	2.4	27782.73 [13044.47, 54270.02]	47373.91 [26874.14, 82068.28]	0.001
HARS	1.4	4597.49 [2318.39, 7798.38]	6565.70 [3958.94, 9588.00]	0.019
HSPB1	2.8	4617.03 [1732.16, 8855.58]	5408.40 [2816.20, 9088.60]	0.160
HSPD1	0.3	3299.42 [1401.20, 8817.68]	4461.00 [2463.66, 10410.47]	0.044
IGLL	25.4	811.69 [330.99, 1564.34]	1283.75 [714.98, 2346.66]	0.006
LYZ	16.0	555.54 [186.65, 7302.15]	263.15 [120.03, 704.77]	0.002
MAPK3	0.7	9830.88 [2458.02, 23857.96]	15368.74 [8359.28, 37116.40]	0.001
MUC5B	24.7	1066.18 [544.56, 1997.16]	1251.97 [640.10, 1880.22]	0.362
NTF3	2.8	4853.19 [2039.01, 12903.88]	13178.46 [5119.04, 31061.95]	<0.001
NTF4	6.3	883.80 [443.35, 1608.61]	1576.92 [788.47, 2718.02]	0.001
OGFR	3.1	1402.66 [696.57, 3144.92]	2163.76 [1257.49, 4107.68]	0.005
PDIA3	18.1	17431.70 [7605.95, 34366.26]	18777.89 [10221.49, 36333.68]	0.539
PKC	9.8	155.38 [70.51, 373.37]	188.74 [87.99, 438.85]	0.265
PPIA	0.7	4817.81 [2002.12, 10294.61]	5839.27 [2960.55, 10091.30]	0.155
PRKCSH	3.1	4898.71 [2353.30, 10513.01]	6255.10 [3161.41, 10863.94]	0.123
rhEPCR	0.7	44095.74 [25652.18, 85043.96]	64727.67 [32507.14, 105013.72]	0.052
SCFD1	1.7	4275.51 [2084.45, 11175.74]	6504.28 [3093.82, 17793.15]	0.032
SERPINA	2.8	1371.35 [692.52, 3150.89]	2362.25 [1633.70, 4431.63]	0.001
SNCA	3.5	1347.53 [647.41, 3002.53]	2669.78 [1139.49, 3811.30]	0.001
SNCG	2.4	29207.40 [9905.51, 61074.74]	35001.63 [20500.83, 63952.74]	0.098
SOD1	23.0	407.98 [110.07, 1046.57]	988.49 [353.56, 3169.13]	<0.001
SPTA1	0.3	2942.47 [1635.98, 5839.15]	4066.71 [2760.73, 6634.58]	0.035
SRP14	3.8	21131.03 [3267.23, 49260.49]	53043.77 [25105.93, 84696.86]	<0.001
TF	13.2	24740.36 [11311.13, 54334.60]	35316.44 [21494.71, 53916.44]	0.044
TG	0.3	48864.84 [28526.26, 87754.27]	68760.55 [40027.30, 112662.03]	0.013
TNNI3	2.1	2227.38 [1014.05, 4739.08]	2584.20 [1507.94, 4812.98]	0.178
TOP1	4.9	8365.60 [4257.88, 18528.31]	9320.98 [5320.86, 23541.94]	0.434
UCHL1	10.8	3014.20 [1257.18, 8253.46]	7115.37 [2077.31, 14879.76]	0.009
USP10	27.9	400.38 [91.67, 1374.01]	190.32 [68.20, 402.91]	0.027
VEGF	8.4	798.44 [319.16, 1490.63]	846.76 [536.98, 1588.95]	0.155
YWHAE	20.2	11895.96 [5219.60, 24643.01]	16298.38 [10034.07, 33682.41]	0.018

Median normalized fluorescence intensity (NFI) with interquartile range is shown for non-RVO and RVO samples.